|
業務類別
|
Biotechnology |
|
業務概覽
|
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market. |
| 公司地址
| 101 Federal Street, Boston, MA, USA, 02110 |
| 電話號碼
| +1 888 958-1253 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.zevra.com |
| 員工數量
| 61 |
| Mr. Justin A. Renz |
Chief Financial Officer and Treasurer |
-- |
20/04/2026 |
| Mr. Neil F. McFarlane, M.S. |
Director, President and Chief Executive Officer |
美元 729.17K |
20/04/2026 |
| Mr. Timothy J. Sangiovanni, C.P.A. |
Interim Chief Financial Officer, Senior Vice President, Finance, Corporate Controller and Principal Accounting Officer |
-- |
09/03/2026 |
| Mr. Rahsaan W. Thompson |
Chief Legal Officer, Secretary and Chief Compliance Officer |
美元 466.67K |
20/04/2026 |
| Dr. Adrian Quartel, F.F.P.M.,M.D. |
Chief Medical Officer |
-- |
20/04/2026 |
| Mr. Joshua Schafer, M.B.A.,M.S. |
Chief Commercial Officer |
-- |
20/04/2026 |
|
|
| Ms. Tamara A. Favorito |
Chairman of the Board |
20/04/2026 |
| Ms. Alicia Secor |
Independent Director |
20/04/2026 |
| Dr. Alvin Shih, M.D. |
Independent Director |
20/04/2026 |
| Mr. Thomas D. Anderson |
Independent Director |
20/04/2026 |
| Mr. Neil F. McFarlane, M.S. |
Director, President and Chief Executive Officer |
20/04/2026 |
| Mr. Douglas W. Calder |
Independent Director |
20/04/2026 |
| Mr. Corey Watton |
Independent Director |
20/04/2026 |
|
|
|
|
